Update on FDA Adjustment to Evusheld Dosage Regimen in US

25 February 2022 -- The US Food and Drug Administration (FDA) has amended the Emergency Use Authorisation (EUA) Fact Sheet for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) for pre-exposure prophylaxis (prevention) of...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials